3,4-dihydroxyphenylacetic acid has been researched along with dextromethorphan in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonuccelli, U; Corsini, GU; Maggio, R; Pardini, C; Vaglini, F | 1 |
Huang, EY; Liu, TC; Tao, PL | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and dextromethorphan
Article | Year |
---|---|
Dextromethorphan prevents the diethyldithiocarbamate enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Chelating Agents; Dextromethorphan; Ditiocarb; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Glutamic Acid; Homovanillic Acid; Male; Mesencephalon; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons; Septal Nuclei; Serotonin; Substantia Nigra; Tyrosine 3-Monooxygenase | 2003 |
Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Conditioning, Operant; Dextromethorphan; Dopamine; Drug Synergism; Male; Microdialysis; Morphine; Motor Activity; Narcotics; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reward; Time Factors | 2003 |